Genelux
GNLX
57 hedge funds and large institutions have $12.4M invested in Genelux in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 20 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
5.49% less ownership
Funds ownership: 20.63% → 15.14% (-5.5%)
11% less capital invested
Capital invested by funds: $14M → $12.4M (-$1.59M)
22% less funds holding
Funds holding: 73 → 57 (-16)
80% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$205K |
| 2 |
WDC
Woodward Diversified Capital
Bakersfield,
California
|
+$205K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$198K |
| 4 |
Millennium Management
New York
|
+$142K |
| 5 |
Renaissance Technologies
New York
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.75M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$1.23M |
| 3 |
Goldman Sachs
New York
|
-$351K |
| 4 |
BlackRock
New York
|
-$216K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$215K |
GNLX Hedge Fund Activity: Q3 2024 in Review
57 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Genelux (GNLX) for Q3 2024, worth a combined $12.4M — down 11% from $14M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of GNLX and 4 opened new positions — a net loss of 16 holders — while 18 trimmed existing stakes and 17 added.
The largest buyer was Marshall Wace, adding an estimated $205K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.75M sold.
- 57 institutional investors held Genelux (GNLX) as of Q3 2024, down from 73 in Q2 2024.
- Funds reported $12.4M of Genelux stock for Q3 2024, down 11% quarter-over-quarter.
- 4 funds opened new Genelux positions in Q3 2024 and 20 closed out, a net change of -16 holders.
- The largest Genelux buyer in Q3 2024 was Marshall Wace, an estimated $205K added.
- The largest Genelux seller in Q3 2024 was Armistice Capital, an estimated $1.75M sold.
Based on aggregated 13F filings for Q3 2024.